0001140361-16-069208.txt : 20160608
0001140361-16-069208.hdr.sgml : 20160608
20160608203933
ACCESSION NUMBER: 0001140361-16-069208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160606
FILED AS OF DATE: 20160608
DATE AS OF CHANGE: 20160608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K
CENTRAL INDEX KEY: 0001238403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 161704782
MAIL ADDRESS:
STREET 1: 3172 PORTER DRIVE
CITY: PALO ALTO
STATE: CA
ZIP: 94034
4
1
doc1.xml
FORM 4
X0306
4
2016-06-06
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001238403
SPIEGELMAN DANIEL K
C/O BIOMARIN PHARMACEUTICAL INC.,
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2016-06-06
2016-06-06
4
S
0
1649
89.14
D
46944
D
Trade made pursuant to a 10b5-1 plan executed on May 9, 2016.
All shares were sold at the same price.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2016-06-08